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Abstract
Omic data analysis is steadily growing as a driver of basic and applied molecular biology
research. Core to the interpretation of complex and heterogeneous biological phenotypes
are computational approaches in the fields of statistics and machine learning. In
parallel, constraint-based metabolic modelling has established itself as the main tool to
investigate large-scale relationships between genotype, phenotype and environment. The
development and application of these methodological frameworks have occurred
independently for the most part, whereas the potential of their integration for biological,
biomedical and biotechnological research is less known. Here we describe how machine
learning and constraint-based modelling can be combined, reviewing recent works at the
intersection of both domains and discussing the mathematical and practical aspects
involved. We overlap systematic classifications from both frameworks, making them
accessible to non-experts. Finally, we delineate potential future scenarios, propose new
joint theoretical frameworks and suggest concrete points of investigation for this joint
subfield. A multi-view approach merging experimental and knowledge-driven omic data
through machine learning methods can incorporate key mechanistic information in an
otherwise biology-agnostic learning process.
Introduction 1
Today, the search for biological mechanisms at molecular scale can leverage an 2
unprecedented amount of information. With the recent development of high-throughput 3
technologies, data collection has received an enormous impulse that has radically 4
changed the perspective towards molecular biology. The main protagonist of this shift is 5
omic data, namely experimental profiles with large coverage over multiple biological 6
domains. Several levels of knowledge have become associated with emerging omic 7
technologies [1–3]. The most widespread to date include DNA sequencing (genomics), 8
microarrays and RNA sequencing (transcriptomics), DNA methylation and histone 9
modifications (epigenomics), and protein or metabolite mass spectrometry (proteomics 10
and metabolomics). As technology moves forward, its associated costs decrease and a 11
growing wealth of data is being generated. Omic data therefore provide direct and 12
convenient access to genetic variability and cellular activity. Undoubtedly, these datasets 13
can be useful only if processed and deciphered through appropriate analytical tools. 14
A fundamental tool for the inspection, interpretation and exploitation of omic data 15
is machine (and deep) learning, which has arguably fueled several leaps forward in 16
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recent research and is expected to increasingly drive it in the near future [4, 5]. Machine 17
learning can be described as a set of algorithms that improve prediction accuracy 18
through experience, given a certain processable input from which they are able to learn 19
and generalize. Beyond their predictive power, their diffusion in bioinformatics and 20
computational biology is also due to the limited assumptions they require compared to 21
other statistical or computational approaches. This makes them essential in a number of 22
tasks, ranging from the understanding of RNA folding to estimating the impact of 23
mutations on splicing, and from the exploration of gene expression profiles to 24
reconstructing phylogenetic trees [6–9]. 25
In parallel, the increase in data and knowledge also favored the development of 26
mathematical models for biomolecular systems. Contrary to data-driven approaches, 27
hypothesis-driven analysis of large-scale omic domains typically remains prohibitive 28
given the difficulty in pinpointing the underlying biological mechanisms. There are 29
however some exceptions. Among the various approaches, constraint-based modelling 30
(CBM) of metabolism is receiving a huge impulse thanks to its wide scope and 31
flexibility, enabling mechanistic insights into the genotype-phenotype-environment 32
relationship via integration with omic data [10]. With the recent advances in technology, 33
we are now able to reconstruct large-scale metabolic reaction networks of prokaryotic 34
and eukaryotic cells, and genome-scale metabolic models (GSMMs) are constantly 35
increasing in number and variety across all life kingdoms [11–15]. 36
These two computational frameworks have mostly been used in isolation, having 37
distinct research communities associated with them. However, we believe that their 38
complementary characteristics and common mathematical bases make them particularly 39
suitable to be combined. Several works implemented this idea in various ways and were 40
partially surveyed before [16,17]. Nevertheless, a comprehensive and systematic 41
overview on this subject is lacking. In this work, we first review the existing approaches 42
for integrating machine learning and CBM by compiling a thorough record of previous 43
studies based on a combined classification of the two frameworks. Then, we suggest 44
possible future research lines to develop new methodological approaches at the 45
intersection of the two fields. 46
We therefore aim at providing a comprehensive and systematic catalog of existing 47
interactions between CBM and machine learning, whilst distinguishing between the 48
various methodological and applicative aspects concerned. In general, the central idea is 49
that GSMMs can be used to generate an additional omic layer: the so-called fluxomic 50
data. The multi-omic learning considered here then integrates this newly generated 51
omic with the ones already available. For instance, concatenation of two datasets 52
following normalization is a viable option. However, we will describe why in practice 53
this may not be the best approach. Although it is outside of the scope of this work, we 54
also remark that other computational techniques have successfully been used to build on 55
CBM approaches and study the multi-omic nature of various organisms. These include 56
Bayesian [18] and meta-heuristic optimization algorithms [19,20], as well as methods 57
drawn from the theory of games [21], graphs [22], Markov chains [23] and 58
information [24]. 59
In the following sections, we first concisely summarize the rationale and scope of 60
machine learning and CBM of metabolism. Next, we review and classify previous 61
studies where these two frameworks were combined. Finally, we discuss similarities and 62
differences among their mathematical bases, evaluate the advantages and limitations of 63
computationally generating omic information, and outline aspects that have not been 64
explored so far. To distinguish among the different types of mathematical models 65
considered, throughout the text we will use the term data-driven to refer to machine 66
and deep learning models, whereas knowledge-driven will refer to constraint-based 67
models. If the meaning is intended to be more general, we will simply use the term 68
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biological model. Overall, we show that mining and integrating experimental and 69
GSMM-generated multi-omic data with machine learning techniques can unveil 70
unknown mechanisms in a sample-specific manner, hence identifying relevant targets for 71
biotechnology and biomedicine. Compared to approaches applying machine learning to 72
omic data directly, we believe that a multi-view approach merging experimentally- and 73
GSMM-generated omic data can include key mechanistic information in an otherwise 74
biology-agnostic learning process. 75
Data-driven exploration of biomolecular systems 76
The key problem in an increasingly omic-based biology is the difficulty in extracting 77
knowledge from large and complex datasets. This task can be conveniently tackled 78
through machine learning algorithms, many of which can be adapted to specific settings 79
and omic types. A number of recent developments in the application of machine 80
learning to problems in molecular biology and biomedicine have been critically analyzed 81
in previous surveys, along with their limitations and challenges [4–9,25–27]. Here we 82
concentrate on recalling the main characteristics of basic methods, with a focus on those 83
suited for the simultaneous analysis of heterogeneous data. 84
Types of machine learning approaches 85
A fundamental distinction in machine learning is between supervised and unsupervised 86
learning approaches. In supervised learning, the goal is to predict one or more targets 87
associated with a given sample. For instance, pathogenicity resulting from mutations 88
can be predicted starting from the sequence as a continuous risk score or a discrete risk 89
class. Broadly speaking, supervised learning methods can be sub-divided into two main 90
categories: classifiers, which aim to predict sample classes (e.g. pathogenic versus 91
non-pathogenic variants), and regressors, whose task is to estimate numerical quantities 92
(such as pathogenicity risk level). Several methods such as support vector machines 93
(SVM) or artificial neural networks (ANN) can be used to solve both classification and 94
regression problems. 95
In contrast, unsupervised learning allows the exploration of data collections by 96
deconstructing variation or correlations among samples. Unsupervised learning 97
approaches are largely classified as either association algorithms, which uncover latent 98
rules or trends in data, or clustering algorithms, which partition samples based on their 99
inherent and often hidden characteristics. Owing to the large volume of omic data, its 100
condensation or simplification can prove to be useful in order to facilitate its 101
interpretation. The most popular approaches for data dimensionality reduction are: (i) 102
principal components analysis (PCA), which reduces data into low dimensional 103
representations summarizing maximum variance among variables; (ii) factor analysis, 104
which decomposes data based on latent relationships describing the correlation between 105
variables; and (iii) matrix factorization, which breaks down data matrices into denoised 106
constituents. For instance, non-negative matrix factorization (NMF) has been used to 107
infer the ecological interaction networks of different gut microbial communities starting 108
from high-dimensional metagenomic samples [28]. Finally, as regards clustering 109
approaches, the most widespread ones fall within the k-means and hierarchical clustering 110
families, but many other algorithms are available with several applications [29]. 111
Machine learning for multi-omic data 112
A single type of data usually offers a partial view on biological complexity and limits 113
our understanding of it. Data integration methods can facilitate the combined analysis 114
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of multiple omic datasets, which may be heterogeneous, in order to more closely 115
represent genotype-phenotype relationships [1, 2, 30–34]. Data may be generated 116
starting from the same samples through different omic measurements, or even with 117
different omic measurements across different samples measured in the same system. As 118
omic domains are inherently interconnected, signals missing from a single dataset can be 119
compensated for in a multi-omic data-driven model, therefore decreasing the likelihood 120
of false negatives. At the same time, the mutual reinforcement of heterogeneous omic 121
signals can limit false positives. 122
Most successful large-scale data integration approaches are meta-dimensional 123
methods, which simultaneously span multiple data sources and can cope with variable 124
inputs [2]. They are broadly categorized into concatenation-based, transformation-based 125
and model-based integration, whose general characteristics are displayed in Figure 1. 126
Alternatively, they are also called early-, intermediate- and late-stage integration 127
methods respectively. In the machine learning context, algorithms dealing with data 128
from multiple heterogeneous sources are referred to as multi-view or multi-modal 129
learning algorithms [35, 36]. 130
Fig 1. Omic data integration methods in machine learning. Multi-view omic
data integration methods can be classified into three main domains. (a)
Concatenation-based (early-stage) integration involves combining all omic data into one
large matrix before applying machine learning (ML) methods to obtain a data-driven
model. (b) Transformation-based (intermediate-stage) integration involves applying
data transformations to obtain a uniform format, which can then permit the
combination into one fused dataset. (c) Model-based (late-stage) integration involves
obtaining individual machine learning models separately for each dataset before
combining the outcomes, rather than combining data prior to the learning phase.
Concatenation-based integration (Figure 1a) fuses multiple data types together 131
by concatenating data matrices into a single comprehensive matrix. Next, a learning 132
algorithm is applied to this combined matrix. An advantage of this approach is the 133
relative ease to apply statistical methods to any final data matrix. However, combining 134
multiple matrices together can be challenging, due to differences in scaling or inherent 135
biases of each data type. Normalization techniques can be used to ensure that data of 136
different orders of magnitude converge on the same scale, but differences in noise and 137
variance can still affect the results [37] and as such, this kind of approach can lack 138
reliability. Moreover, a data reduction step may be necessary if too many variables 139
make the analysis infeasible. 140
Transformation-based integration (Figure 1b) converts each dataset into an 141
intermediate form such as a graph or a kernel matrix (i.e. a matrix describing a precise 142
mathematically-defined similarity among observations) [38]. The integration of the two 143
datasets is then performed at the level of transformed data, hence resulting in a 144
integrative graph or kernel matrix, which is used in the learning phase. This approach 145
has the advantage of preserving the original properties of the data and the capability to 146
combine virtually any data structure or format by applying the appropriate 147
transformations. The main disadvantage is the difficulty of detecting interactions 148
among different sources, missing cross-omic correlations and therefore resulting in hard 149
interpretation. 150
Model-based integration (Figure 1c) generates machine learning models from 151
each dataset and subsequently combines them to produce a final data-driven model. 152
This kind of integration can have even larger flexibility compared to the 153
transformation-based approach. For instance, in patient-centered studies, it is possible 154
to combine models coming from various groups of patients for which different data 155
sources have been analyzed. However, this strategy can miss interaction among different 156
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data types as well. Furthermore, it is particularly sensitive to over-fitting, so it is 157
recommended when the data pool is extremely heterogeneous. 158
All these strategies are commonly applied to heterogeneous datasets obtained from 159
different experimental sources. However, there are also computational methods for 160
generating data on the omic levels where empirical means are inadequate. In particular, 161
we concentrate on CBM of metabolism, as described in the following section. 162
Constraint-based analysis of metabolic networks 163
Metabolism is one of the major biological components that co-participates with the 164
genotype in composing the phenotype. Metabolites can generate signals that are 165
received at other omic levels, while metabolic feedbacks can compensate or modify 166
genetic and environmental signals through complex non-intuitive routes [39,40]. 167
Unfortunately, omic-scale metabolite probing is still immature and suffers from major 168
limitations. The main obstacles are high biochemical heterogeneity and concentration 169
variations that can occur within sub-second time scales and span several orders of 170
magnitude [41,42]. In turn, metabolic reaction fluxes cannot be directly measured at 171
large scale, and their estimation from indirect measurements presents even more 172
challenges [43]. 173
Genome-scale metabolic models (GSMMs) 174
Despite these experimental difficulties, metabolism remains the domain in molecular 175
biology with the vastest knowledge, accumulated over the past century. Reconstructions 176
of entire metabolic reaction networks have immediately followed after completing the 177
first genomes in the late 1990s [44,45]. GSMMs are mathematical representations of 178
such networks and their relationships with associated enzymes and encoding genes, 179
comprising the metabolic functionality of a cell [46]. A vast range of computational 180
methods have been developed upon the framework of GSMMs to investigate interactions 181
between genotype, environment and phenotype [17,47,48]. Acting as integrative 182
platforms for multi-omic data, they can also help identify non-intuitive phenomena in 183
metabolism [49]. Importantly, they also enable evaluation of the complete metabolic 184
state of cell populations even when metabolome profiling is infeasible. 185
The mathematical framework of GSMMs is grounded on two physical assumptions. 186
First, mass and charge conservation, which guarantees that the total mass of produced 187
substrates equals the total mass of those consumed. Second, the system must be at 188
steady state, meaning that internal metabolite concentrations do not change over time. 189
The steady-state assumption differentiates CBM from the modelling based on ordinary 190
differential equations. The latter allows the study of metabolic systems in dynamical 191
conditions, but it is computationally expensive and requires detailed knowledge of initial 192
metabolic conditions and kinetic reaction parameters. For these reasons, it is only 193
feasible for small systems, and therefore cannot capture long-range phenomena or 194
general metabolic reprogramming. Conversely, GSMMs are restricted to steady-state 195
conditions, but they can span the entire cellular metabolism or even multi-cellular 196
communities [50]. 197
Modelling fluxes can be crucial for gaining a better understanding of both metabolic 198
activity and wider biological phenomena [10]. At a reaction and pathway level, flux 199
balance analysis (FBA) is currently the most widely used tool to estimate the flow of 200
metabolites in metabolic networks [46]. FBA allows determination of the flux 201
configuration that yields maximal or minimal rate through one or more target reactions. 202
In its basic form, it is mathematically defined as a linear optimization problem targeting 203
a subset of reaction fluxes (Figure 2). Usually, when no other obvious cellular objective 204
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is involved, the maximization of biomass is considered as a reasonable goal for bacteria 205
under evolutionary pressure, but also for cancer cells under a proliferative regime [51]. 206
For other types of cells, identifying the true objective is still a challenge, therefore 207
biomass is commonly taken as a reasonable proxy. Various FBA variants take into 208
account further biological constraints or regularizations, and are defined as quadratic, 209
mixed-integer or multi-level programs [52]. 210
Fig 2. Constraint-based data integration and fluxome generation. (a)
Constraint-based metabolic modelling begins with the construction of a
manually-curated GSMM recording all reactions taking place in the network. (b) Coded
within the structure of a GSMM is the stoichiometric matrix S, denoting the
involvement of metabolites in each reaction. Constraints are applied to the model to
identify a given metabolic goal, represented as the objective function c, and using linear
or quadratic optimization to maximize or minimize this objective. The steady state
assumption (Sv = 0) sets the product of the stoichiometric matrix S and flux vector v
as invariant. (c) To compute a unique flux distribution, the objective function can be
regularized by subtracting a concave function from it. In addition to v being restricted
between default lower and upper limits (vmin and vmax), external multi-omic data θ can
be used to further constrain fluxes using the mapping function ϕ(θ), hence driving the
output towards condition-dependent solutions.
Condition-specific constraint-based models 211
In a typical constraint-based metabolic model, fluxes are the variables whose values 212
have to be determined. Since there are usually a greater number of reactions than 213
metabolites in a GSMM, the problem is under-determined - meaning that multiple 214
solutions can satisfy it. In order to determine biologically meaningful solutions, it is 215
often necessary to further refine the model by applying additional biological, physical or 216
chemical constraints. For example, these may account for enzyme capacity and 217
promiscuity, spatial occupation, metabolite sequestration and multiple levels of gene, 218
transcript and protein regulation [53]. Constraints derived from experimental data are 219
particularly useful as they are employed to build GSMMs that directly reflect observed 220
biological conditions, e.g. those in particular tissues or pathological states. 221
The development of condition-specific or context-specific GSMMs constitutes a 222
further data integration framework, as shown in Figure 2. In this case, the process 223
starts from raw data and knowledge on cellular physiology that are aggregated and 224
converted into a GSMM. Although in the early phases of this field global 225
reconstructions were built by long manual efforts to aggregate and make sense of 226
scattered information, methods to partially automate this process are now available, 227
and in principle they can be used to construct hundreds of knowledge-driven 228
models [54–56]. General purpose GSMMs can then be used as scaffolds for the 229
successive integration where omic data are mapped onto it, obtaining newly refined 230
models with additional constraints. Mapped data can be transcriptomic, proteomic and 231
metabolomic profiles, or information on splice isoforms or codon usage, as implemented 232
in a number of works and software packages [57,58]. Depending on the external data 233
introduced, it is possible to generate GSMMs that reflect specific properties or states of 234
particular tissues, cell types, microbial strains, or even individual cells. 235
Transcriptional profiles are the most popular omic to build context-specific GSMMs, 236
via an array of methods utilizing different contextualizing criteria [17, 59]. Switch-based 237
methods utilize a gene expression threshold to turn off reactions associated with lowly 238
expressed genes, thereby pruning the metabolic network. Conversely, valve-based 239
methods map the transcriptional information on the constraint-based model in a 240
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continuous fashion. There are instead fewer approaches focused on the integration of 241
proteomic and metabolomic data [60]. Commonly, algorithms such as iMAT [61], 242
INIT [62] and METRADE [20] provide a framework for integrating both gene and 243
protein expression data, with IOMA providing the opportunity to integrate proteomic 244
and metabolomic data [63]. However, more specific approaches for protein data are 245
being developed. For instance, a method known as GECKO constructs a GSMM with 246
enzymatic constraints using kinetic and omic data [64]. This is achieved by expanding 247
the stoichiometric matrix of the GSMM to include rows representing enzymes and 248
columns representing enzyme usage in reactions, while enzyme kinetics (kcat values) is 249
modelled by pseudo-stoichiometric coefficients in this matrix. Constraining protein 250
abundance in this way has the effect of significantly reducing flux variability and 251
improving the accuracy of the predictions. Methodology and applications for 252
condition-specific GSMMs have been reviewed in detail elsewhere [53,59,65,66]. 253
Combining constraint-based analysis and machine 254
learning 255
The integration of CBM of metabolism with machine learning is based on two key ideas. 256
The first is that genetic and environmental perturbations propagate in a non-linear 257
fashion through metabolic networks and assume patterns on a reaction flux level that 258
may be used to gain mechanistic insights into several research questions. The second is 259
that GSMMs can act as both an analytical framework to represent biological systems 260
and generators of information to be mined. In other words, flux solutions obtained by a 261
GSMM can be treated like additional numerical data (another omic layer) and analyzed 262
via learning algorithms. With the knowledge-driven metabolic model being set, the 263
information extracted from it may depend on the task of interest and on the variables 264
deemed relevant. As a result, it is possible to leverage the whole array of techniques 265
defined on CBM [47] (see section Constraint-based analysis of metabolic networks). 266
Additionally, constraints at the metabolic level can be used to enhance the learning in 267
multi-omic settings, as explained in the following. 268
Despite these potential advantages, such integrated methodologies have remained 269
confined to a few studies so far. In this section - to the best of our knowledge - we 270
outline the existing examples of integration between machine learning and CBM 271
grouped based on the task type as shown in Table 1 and Figure 3. 272
Fig 3. Multi-omic data analysis by combination of constraint-based
modelling with machine learning. (a) Fluxomic analysis involves FBA or related
techniques performed on a general-purpose GSMM, from which the flux data obtained
can be used as input for unsupervised or supervised machine learning. (b) To improve
the accuracy of machine learning predictions, multi-omic datasets are obtained using
high-throughput analytics, e.g. transcriptomics (DNA microarrays, RNA sequencing),
proteomics (2D gel electrophoresis, stable isotope labelling, mass spectrometry) or
metabolomics (NMR spectroscopy, isotopic labeling, LC-MS, GC-MS). As these datasets
are obtained from different sources, they must undergo several preprocessing stages such
as filtration and normalization to maintain synchronicity, account for variance and
reduce noise. Condition-specific knowledge-based models are generated by introducing
these multiple datasets into GSMMs to obtain more precise flux estimations, from
which machine learning techniques can be applied to infer biologically-relevant patterns
in the data. (c) Alternatively, machine learning can be directly applied to single- or
multi-omic datasets, to produce or improve GSMMs or fluxomic data.
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Supervised fluxomic analysis 273
The baseline case is when biological targets are predicted based solely on metabolic 274
fluxes obtained from general purpose GSMMs. The output of FBA or related techniques 275
can then be fed to algorithms for supervised analysis, without data integration being 276
involved (see Table 1). 277
For instance, Sridhara et al. investigated whether bacterial growth conditions could 278
be inferred from intracellular flux configurations [67]. Multinomial logistic regression 279
was used in conjunction with least absolute shrinkage and selection operator (LASSO) 280
regularization to relate growth conditions to simulated metabolic fluxes. The regression 281
enabled prediction of growth conditions for a particular FBA solution by using internal 282
metabolic fluxes as input, with regularization serving to select the most relevant fluxes 283
and prevent over-fitting. 284
In the context of human metabolism, integration of constraint-based models and 285
machine learning has been shown to correctly identify side-effects of inhibitory drugs 286
with higher accuracy than baseline methods [68]. Drug-specific actions were simulated 287
by in silico gene deletions, and the associated metabolic perturbations were estimated 288
through flux variability analysis (FVA), whose results were fed to an ensemble SVM. 289
Artificially-reproduced metabolic alterations improved the results, compared to a 290
predictor used on drug biochemical structures. In a similar fashion but for a different 291
objective, a deep neural network and a differential search algorithm were applied to 292
design gene deletion interventions in E. coli for the production of xylitol [69]. Also in 293
this case, FBA coupled with artificial gene knockout served as a generator of 294
genome-scale fluxomic data. Another recent study tested a flux-based data-driven 295
approach for the prediction of titre, production rate and yield across different 296
bioprocessing settings [70]. Based on an ensemble of state-of-the-art machine learning 297
techniques, flux features were shown to boost predictive accuracy in this scenario, 298
typically characterised by sparse data. 299
Importantly, CBM and machine learning can be formulated as a joint problem by 300
embedding stoichiometric constraints in a learning task. As an example of supervised 301
method, a discriminant analysis technique based on metabolic network constraints - 302
called dynEMR-DA - was defined to identify pathway activation patterns that best 303
discriminate between experimental conditions [71]. The methodology expands the 304
concept of elementary flux modes (EFMs) - which are the simplest paths in a GSMM 305
that characterize the associated flux space - to dynamic conditions. The algorithm seeks 306
to determine the EFMs that differ the most in terms of time evolution. 307
Expanding the analysis of fluxes to an ecological scale, DiMucci et al. developed an 308
approach to predict interactions among bacterial species starting from temporal 309
simulations of co-cultures through dynamic flux balance analysis (dFBA) [72]. A 310
random forest classifier was trained on binary vectors representing the exchange 311
reactions in each GSMM, using dFBA relative yield predictions of co-cultures with 312
respect to independent cultures. This data-driven model allowed better generalization 313
than the simple distance-based criterion commonly employed in microbial community 314
studies, and also allowed inferring the metabolic exchanges underlying the predicted 315
interactions. In another ecological context, Chien and Larsen proposed that supervised 316
classification of niches of bacterial species can benefit from the information generated by 317
metabolic models [73]. They reconstructed GSMMs for 21 Pseudomonas species living 318
in the endosphere and rhizosphere, and simulated 12 media formulations in order to 319
generate predictive features. A cross-comparison of SVM, ANN and NMF suggested 320
that metabolic flux features may be more predictive than purely genomic features. 321
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Unsupervised fluxomic analysis 322
The exploration and statistical characterization of fluxomic profiles extrapolated from a 323
GSMM can be of interest to shed light on the underlying physiology. In the absence of a 324
well-defined biological target, unsupervised machine learning approaches can generally 325
characterize correlation or variation across multiple samples. This allows clustering 326
metabolic states or describing them in terms of sparser sets of variables. 327
This was first realized by Segre et al., who exploited a GSMM to explore epistasis in 328
yeast metabolism [74]. The task was accomplished by performing agglomerative 329
clustering on the fitness landscape of single and double deleterious mutants for all genes 330
involved in metabolism, where the fitness was defined on FBA growth rate ratios. The 331
analysis identified a widespread modular organization of genes into groups linked 332
exclusively by buffering or aggravating epistatic interactions, leading the authors to 333
extend the concepts of modularity and epistasis based on the observed inter-module 334
connections rather than on intra-module properties. An analogous approach was 335
employed in the context of gut microbiome ecology, where Magnu´sdo´ttir et al. 336
performed a large-scale study on the ecological interactions among community members 337
across a combination of western or high-fibre diets and aerobic or anaerobic 338
conditions [75]. Similarly, these interactions were evaluated in terms of hierarchical 339
clustering of the relative growth between interacting and non-interacting pairs predicted 340
through FBA. The microbes were then profiled based on their interactions, identifying 341
three major subgroups enriched in species with different carbohydrate fermentation 342
capabilities. Positive interactions were observed mainly among metabolically-distant 343
organisms, confirming independent studies. 344
Furthermore, dimensionality reduction techniques can be employed to deconstruct 345
the entire flux space associated with constraint-based models, as done for E. coli [76]. 346
In this case, PCA served to filter and synthesise the variation in biochemical reaction 347
fluxes achievable by the metabolic network. Non-trivial cross-correlations among 348
pathway activities can be captured, and associated metabolic capabilities can be 349
comprehensively evaluated in terms of imposed constraints. 350
Finally, like in the supervised scenario, the analysis of multiple flux profiles can 351
benefit from constraining a learning objective with stoichiometric knowledge. 352
Alternative hybrids of PCA and stoichiometric flux analysis, termed as principal 353
elementary mode analysis (PEMA) and principal metabolic flux mode analysis (PMFA), 354
extract flux modes generated by metabolic models which contribute the most 355
significantly towards variance, whilst penalizing deviations from the steady state [77,78]. 356
These methods are able to overcome some of the shortcomings of using general PCA for 357
the statistical interrogation of flux distributions, e.g. the overlooking of reaction 358
stoichiometry and the need for a predefined set of pathways. PEMA was also extended 359
to analyze non steady-state EFMs [71]. 360
Supervised multi-omic analysis 361
When experimental data is available, it can be aggregated with CBM-generated 362
fluxomes to build multi-omic sets of features and predict targets of interest. Thanks to 363
the peculiar advantages of each individual data-integration approach, there are multiple 364
ways to combine them depending on the questions addressed and on the available 365
resources. One-stage integration by machine learning methods is a possibility, as 366
described in Section Machine learning for multi-omic data. 367
This strategy was first investigated to predict metabolic reaction essentiality in E. 368
coli. FBA-like approaches coupled with artificial gene deletions can efficiently estimate 369
essential reactions, although this often requires precise knowledge of nutrient availability 370
in a given condition. The essentiality is usually evaluated merely based on the biomass 371
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accumulation rate, which may be an imprecise estimator in some cases. Plaimas and 372
co-workers [79] investigated whether it could be possible to improve FBA predictions by 373
combining the estimated growth rate with additional topological, genomic and 374
transcriptomic data. By using a SVM as classifier, they successfully verified an 375
improvement in accuracy. An analogous approach was used by Szappanos et al. to 376
predict positive and negative genetic interactions in S. cerevisiae [80]. A random forest 377
was trained with FBA-based fitness and genetic interaction scores in addition to a large 378
array of gene-pair characteristics such as paralogy, protein annotations, protein 379
interaction network topology, single deletant fitness, mRNA expression, quantitative 380
phenotypic correlation and compartment localization. Traditional features were shown 381
to give low precision for the majority of gene interactions, while FBA-based features 382
brought significant improvements in predictive precision and recall, indicating that 383
genome-scale CBM captures relevant information that is missed by gene-level 384
traditional features. The approach was tested again in the context of gene essentiality 385
prediction by Nandi et al. [81], who instead employed flux coupling analysis (FCA) as 386
feature generator to take gene adaptability into account in varying environmental 387
conditions [82]. 388
However, the metabolic capabilities of a cell population vary according to 389
environmental and genetic conditions. For the sake of prediction, it is therefore 390
important that metabolic information extracted by GSMMs reflects the differences 391
between these conditions. This can be achieved through the creation of 392
condition-specific metabolic models (Section Condition-specific constraint-based 393
models). This constraint-based integration was used for the first time by Li et al. to 394
predict novel drug-reaction interactions in cancer [83]. They employed a linear 395
programming model to enforce the agreement between gene expression and metabolic 396
fluxes in order to determine fluxomic profiles relative to 59 cell lines, which were used 397
for binary classification by a kernel k-nearest neighbor (kNN) model. A similar 398
procedure was used to explore the molecular biology of aging [84]. Using the 399
transcriptomic data from the CD4 T-cells of 499 healthy participants, personalized CD4 400
T-cell metabolic models and their fluxomes were obtained with a continuous gene 401
expression map [20]. Applying elastic net regression to these individual metabolic fluxes 402
and the chronological ages of the individuals allowed establishing metabolic age 403
predictors and their effect sizes. Using these poly-omic predictors, the metabolic age of 404
an individual could be defined and calculated, providing a basis for improved prediction 405
of individual aging and life expectancy. A similar strategy was employed to 406
metabolically and mechanistically evaluate the impact of synthetic mutations in 407
Pseudomonas putida starting from corresponding gene expression measurements [85]. 408
Effectively learning from empirical omic profiles and associated GSMM-based 409
metabolic states necessitates fully exploiting all the variety of multi-omic analysis 410
methods. In this case, a two-stage integration can be achieved through the creation of 411
condition-specific GSMMs and the subsequent machine learning-based data integration. 412
This idea was used to predict the metabolic capabilities of Chinese hamster ovary 413
(CHO) cells for diverse growth conditions [86]. In the study, it was shown that 414
combining fluxomic and transcriptomic data in mammalian cells can provide a better 415
estimation of secondary metabolite production such as lactate. The pipeline includes 416
building bioreactor-specific GSMMs and bi-level FBA optimization [20], which provided 417
information on the metabolism associated with each growth condition. Later, both 418
fluxomic and transcriptomic data was used to predict lactate accumulation with 419
improved accuracy. Considering a wider omic array, Kim et al. developed a general 420
framework for multi-omic inference based on various machine learning methods [87]. 421
Their platform can be used to perform cross-omic predictions among five biological 422
layers: transcriptomic, proteomic, metabolomic, fluxomic and phenomic. All of them 423
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are composed of experimental data aggregated from a number of studies, except the 424
fluxomic layer which is the result of condition-specific FBA following the integration of 425
transcriptomic and proteomic data. 426
More sophisticated data-integration pipelines have also been developed. A study 427
used a method similar to sparse group LASSO to identify phenotypic extreme currents 428
(ECs) based on a combination of metabolic network features and gene expression 429
data [88]. Extreme pathways are sub-pathways (i.e. a subset of largely invariant 430
pathways in the metabolic network that consistently yield steady-state flux), which are 431
decomposed by linking them with a given phenotype. In other words, all ECs were 432
associated with a gene set; based on gene expression data, those displaying a 433
statistically-significant association to a given clinical phenotype were identified. 434
Uncertainty in the kinetic properties of enzymes is one of the main challenges in 435
developing kinetic models of metabolism. Andreozzi et al. designed a strategy called 436
iSCHRUNK to minimize such uncertainty [89], where fluxomic and metabolomic data 437
are integrated with a GSMM to create a thermodynamically-consistent GSMM. 438
Subsequently, decision trees are used to evaluate kinetic parameters. Finally, a recent 439
work has used CBM to support an artificial neural network (ANN). DeepMetabolism is 440
an ANN method that integrates unsupervised pre-training with supervised training to 441
build a deep learning model with the ability to predict phenotypic outcomes [90]. In its 442
five-layer autoencoder, the first input gene layer was followed by two encoder layers 443
(protein layer, phenotype layer) and the last two layers were decoders (reconstructed 444
protein layer, reconstructed gene layer). Connections between the layers were regulated 445
by biological priors, with FBA used to set the connectivity between the proteomic and 446
the phenomic layer and therefore embed metabolic knowledge in the ANN architecture. 447
Unsupervised multi-omic analysis 448
Like in the supervised case, unsupervised algorithms can be applied on heterogeneous 449
sets of experimental and GSMM-generated omic profiles. For instance, environmental 450
condition-specific metabolic modelling was combined with statistical modelling by 451
Angione et al. to estimate the metabolic pathway activation cascade triggered by 452
different environmental stimuli [91]. The methodology was shown to better characterize 453
the relationships among different pathways compared to static analysis, especially those 454
occasionally interacting depending on the environmental conditions. In the same 455
fashion, varying genetic conditions can be characterized in terms of associated changes 456
on the metabolic level, and potentially exploited in synthetic biology studies. For 457
instance, decomposition of mutant-specific fluxomic profiles through PCA lead to 458
identifying novel biomarkers for rhamnolipids production [85]. Analogously, Yaneske 459
and Angione utilized both agglomerative hierarchical clustering (AHC) and k-means 460
clustering on transcriptomic data and fluxomic profiles in order to characterize the 461
aging process in human [84]. Subsequent comparison of the clustering between 462
transcriptomic and fluxomic data revealed that fluxomic profiles were better predictors 463
of chronological age and age-associated metabolic biomarkers. 464
Moreover, metabolism and GSMMs can be used as a basis to understand underlying 465
genomic variation. The Gene Expression Latent Space Encoder (GEESE) is a recently 466
proposed approach [92] where transcriptomic information is fed into a deep generative 467
model (specifically, a variational autoencoder) combined with a GSMM. Initially, gene 468
expression data is provided as an input to the autoencoder, returning reconstructed 469
gene expression vectors which are then used to train an FBA approximator. The deep 470
generative model is trained to minimize the loss between the fluxes obtained by passing 471
the reconstructed gene expression through the approximated FBA and the fluxes 472
generated by the real FBA, whilst keeping the weights of this approximator constant. 473
Based on this approach, latent patterns in gene regulation could therefore be identified 474
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while mechanistically accounting for downstream metabolic perturbations. 475
Generation of constraint-based models and fluxomic data 476
Besides analyzing fluxomes generated via CBM, machine learning can be combined with 477
CBM itself to acquire novel fluxomic information. For instance, a suite of different 478
machine learning algorithms (SVM, kNN and decision trees) was used to directly 479
predict fluxomic configurations starting from genetic and environmental factors [93]. 480
The training was performed by aggregating 13C metabolic flux analysis estimations with 481
associated genetic and environmental information from a cohort of studies. In a second 482
stage, the predicted flux outputs were adjusted to satisfy stoichiometric constraints 483
using quadratic optimization, in order to account for the flux balance and boost their 484
accuracy. 485
While in the previous paragraphs we have presented examples of machine learning 486
applications on FBA outputs, data mining can even be used as a preliminary step to 487
gain additional constraints for CBM. For example, Brunk et al. [94] applied a series of 488
multivariate analysis methods (including PCA) on metabolomic data to better 489
understand inner correlations and identify key metabolites influencing inter-strain 490
variation. Consequently, this enabled fixing sets of flux constraints inside the E. coli 491
GSMM and achieving a better characterization of each culture phase. This strategy also 492
allows estimating metabolic fluxes in conditions that are not directly accessible to FBA, 493
such as in unsteady-state flux balance analysis (uFBA), where multiple flux profiles 494
associated with dynamic conditions can be predicted [95]. The underlying idea is to use 495
PCA and linear regression to define constraints for a FBA model starting from 496
metabolomics data. Since whole-metabolome measurements are generally difficult to 497
achieve, uFBA also includes an algorithm to estimate unmeasured metabolite 498
concentration differences on the basis of those that are measured. The obtained 499
constraint-based model can be used for traditional FBA, FVA or related analyses in 500
dynamic conditions. Finally, an ensemble of methods was used to estimate enzyme 501
catalytic turnover bounds for a whole E. coli GSMM, improving its predictions on 502
proteome allocation compared to the integration of turnover rates measured in 503
vitro [96]. It is interesting to note that, in this case, FBA solutions associated with 504
random environmental conditions were also included in the supervised learning phase, 505
corresponding to a fluxomic analysis as described in Section Supervised fluxomic 506
analysis. 507
Table 1. Overview of previous studies that integrated constraint-based modelling and
machine learning, grouped by task type.
Study Data integration Machine learning CBM Task
approach component component
Supervised fluxomic analysis
[67] - Regularized multinomial logis-
tic regression
FBA Prediction of growth conditions
[68] - Bagging SVM, random forest FVA, gene deletion Inhibitory drug side effect prediction
[69] - ANN FBA, gene deletion Prediction of xylitol production
[73] - SVM, ANN, NMF FBA Prediction of bacterial ecological niches
[72] - Random forest dFBA Prediction of ecological interactions
[71] - Discriminant analysis Elementary flux modes Identification of distinguishing metabolic
patterns between conditions
[70] - PCA, SVM, elastic net, random
forest, XGBoost, kNN, ANN,
ensemble learning
FBA Estimation of titre, production rate and
yield of microbial factories
Unsupervised fluxomic analysis
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Table 1 continued from previous page
[74] - Hierarchical clustering FBA Characterization of epistasis in yeast
metabolism
[76] - PCA Random sampling Decomposition of metabolic flexibility
[77] - PCA Elementary flux modes Identification of metabolic patterns
[75] - Hierarchical clustering FBA Exploration of ecological interactions
[78] - PCA Stoichiometric constraints Identification of responsive pathways





SVM FBA, reaction deletion Reaction essentiality prediction
[83] Constraint-based Kernel kNN Maximization of consis-
tency between reaction ac-




Random forest, logistic regres-
sion




RNN, LASSO regression, en-
semble learning
FBA Cross-omic states prediction in E. coli
[89] Constraint-based Decision trees TFBA Estimation of kinetic parameter range and
identification of key enzymes
[81] Concatenation-
based
SVM-RFE FCA Prediction of gene essentiality
[88] Transformation-
based




Elastic net regression, PCA,
GLM
Bi-level FBA Prediction of lactate production in CHO
cells
[90] Model-based ANN, autoencoder FBA, gene deletion Phenotypic predictions in E. coli based
on multi-omic data
[84] Constraint-based Elastic net regression Bi-level FBA Identification of poly-omic predictors of
aging
[85] Constraint-based Elastic net regression Geometric FBA Identification of disrupted pathways in P.
putida mutants
Unsupervised multi-omic analysis
[91] Constraint-based Bayesian factor modelling Bi-level FBA Prediction of temporal pathway activation
in E. coli
[84] Constraint-based Hierarchical clustering, k-
means clustering
Bi-level FBA Poly-omic characterization of aging




ANN Stoichiometric constraints Interpretation of gene expression data in
E. coli
Generation of constraint-based models and fluxomic data
[93] - kNN, decision trees, SVM Stoichiometric constraints Metabolic flux estimation based on gen-
eral genetic and environmental conditions
[94] Constraint-based PCA FBA, Monte Carlo sam-
pling
Characterization of engineered E. coli
strains variation





Elastic net regression, random
forest, neural networks, ensem-
ble learning
FBA, pFBA, ME model Prediction of proteomic data
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Table 1 continued from previous page
The studies reviewed here and included in the table are grouped by task type: supervised or unsupervised
fluxomic analysis, supervised or unsupervised multi-omic analysis, generation of constraint-based models
and fluxomic data. Each study is annotated with the methodological building blocks related to the two
computational frameworks (CBM and machine learning). List of abbreviations: support vector machine
(SVM), artificial neural networks (ANN), non-negative matrix factorization (NMF), principal component
analysis (PCA), extreme gradient boosted trees (XGBoost), k-nearest neighbors (kNN), recurrent neural
networks (RNN), least absolute shrinkage and selection operator (LASSO), SVM based on recursive
feature elimination (SVM-RFE), generalized linear models (GLM), flux balance analysis (FBA), flux
variability analysis (FVA), dynamic flux balance analysis (dFBA), thermodynamics-based flux balance
analysis (TFBA), flux coupling analysis (FCA), parsimonious flux balance analysis (pFBA), metabolism
and gene expression GSMM (ME model).
Perspective 508
As detailed in the previous section, a number of data- and knowledge-driven workflows 509
can be devised depending on the research goals and on the available resources. Ideally, 510
multi-omic settings appear the most promising for effectively grasping meaningful 511
biological patterns, not only because of the well-known advantages of data integration, 512
but also considering the complementary characteristics of experimental and 513
GSMM-based data. In the following we firstly articulate this point (Section Advantages 514
and limitations of expanding the multi-omic array in silico), highlighting the strengths 515
and limitations of both omic types. In Section Emerging applications, we outline 516
important scenarios where we believe this multi-omic machine learning framework could 517
be applied, and which are largely or entirely unexplored so far. 518
At the same time, many novel integrative methods could be developed given the 519
variety of algorithms existing within the machine/deep learning and CBM frameworks. 520
In particular, in the last section we discuss two related aspects that we believe could 521
inspire the design of novel integrative methods: the importance of interpretability in 522
biological data-driven models and the connections of both CBM and machine learning 523
to mathematical programming (Section Building on common mathematical roots: 524
towards predictive and interpretable biological models). 525
Advantages and limitations of expanding the multi-omic array 526
in silico 527
Due to their generation process, fluxomic profiles obtained through a GSMM provide an 528
alternative and mechanistic perspective on the underlying biology compared to 529
traditional omics. Both possess complementary benefits and drawbacks in scientific and 530
operational terms, as outlined in the following, which make them particularly suitable 531
for integration. 532
As previously pointed out, important differences exist first of all in terms of genetic 533
coverage and prior knowledge [97]. Experimentally-generated omic data can span vast 534
portions of the genome, transcriptome or proteome, despite the limitations of some 535
technologies to achieve full coverage [98]. CBM is instead normally limited to metabolic 536
networks, although extensions to other domains have been advanced [99,100]. Second, 537
generation of traditional omics requires no prior information, whereas GSMM 538
construction assumes extensive knowledge of the metabolic system under consideration, 539
although a semi-automated knowledge-driven model creation partially alleviates this 540
burden [54–56]. On one hand, experimental data generation can be therefore more 541
readily translated to new systems. On the other hand, experimental data is also prone 542
to contain false-positive cues and can sometimes be superficial or ambiguous in its 543
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biological meaning. For instance, the high expression level of a gene does not necessarily 544
lead to an increased enzyme activity if it is part of an enzymatic complex, as it would 545
be limited by the expression of the other genes in the complex. Conversely, GSMMs are 546
usually highly curated and provide a mechanistic description of biological processes, 547
linking together genes, enzymes, metabolites and reactions. GSMM are therefore able to 548
account for isozymes and enzymatic complexes through gene-protein-reaction rules. 549
Compared to annotations with an abstract structure, they can also describe the 550
functional role of genes more precisely as they provide a direct representation of 551
biochemical processes. Despite their well-defined meaning, the scope and precision of 552
fluxes generated in silico is however limited by the quality of the metabolic model used, 553
and by the available knowledge and understanding of a system, which may often be 554
partial. 555
If experimentally-generated omics are the first step towards a comprehensive 556
understanding of living systems, the use of condition-specific GSMMs can therefore help 557
contextualize and interpret them on a large scale. This fusion can also help identify 558
gaps or inconsistencies in knowledge-driven models and maintain a comprehensive 559
biological scope. Likewise, errors arising during experimental measurements might be 560
mitigated through constraint-based integration, also controlling for biological soundness. 561
Furthermore, cost and time factors may motivate the integration of the two data 562
types, though distinguishing between a GSMM, its condition-specific variants, and the 563
calculation of flux data. The initial building and curation of general-purpose 564
knowledge-driven models can in fact be time-consuming and require up to months or 565
even years, despite aid from computational pipelines [101]. However, if a baseline 566
GSMM is already available, the creation of context-specific counterparts and associated 567
flux solutions is generally fast through dedicated software. Besides, the generation of 568
experimental omic data is notoriously cheaper than ever, but remains a non-negligible 569
cost especially when dealing with numerous samples. For cell systems with already 570
validated GSMMs, FBA and related techniques can therefore quickly provide an 571
additional omic layer to integrate with the others at extremely low cost. This 572
consideration is especially important in the case of large sample numbers, which are 573
essential for machine learning methods to identify robust and biologically meaningful 574
patterns. 575
There are nevertheless unsolved issues involving, to some extent, all omic data types 576
and posing major limitations to studies based on them. In particular, we mention the 577
quality of estimated biological phenomena and related biases. As previously mentioned, 578
experimental measurement is subject to intrinsic noise and uncertainty that has to be 579
corrected through appropriate normalization, and small numbers of technical replicates 580
may undermine the statistical significance of the observed signals. Additionally, 581
traditional omics are affected by sampling or technology-specific systematic errors [102], 582
in particular batch effects [103]. In some cases, technology-specific issues can even 583
compromise the overall data quality, like in the sequencing of PCR-challenging 584
regions [98]. Besides, in silico calculation of fluxomes has to deal with uncertainty and 585
bias on different levels as well. The steady-state assumption poses a limit to the kind of 586
fluxomes that can be reasonably estimated [104], and in several situations it may be 587
unclear how to choose among multiple valid flux solutions. In addition to this, 588
uncertainties arising in experimental settings may propagate to omic-based 589
condition-specific GSMMs. As a result, external validation of FBA-predicted fluxes is 590
generally required, at least on the level of cellular growth or most relevant pathways. 591
Thorough GSMM evaluations are highly beneficial for the improvement of these 592
platforms, but they have been conducted only in a limited number of systems, such as 593
E. coli and S. cerevisiae [105–109]. However, as a consequence of the iterative 594
refinement of GSMMs through the accumulation of new knowledge and data, their 595
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coverage and quality are rapidly increasing [14,110]. 596
All these points are very important to bear in mind for a correct and meaningful 597
analysis and interpretation of the underlying biology. Overall, knowledge-driven 598
fluxomic data relies on strong assumptions that require cautious evaluation to ensure 599
biological soundness. At the same time, experimental data generation has to deal with 600
issues that in some cases risk undermining any scientific conclusions. For these reasons, 601
signals obtained from both experimental and GSMM-based omic studies should always 602
be thoroughly evaluated through careful study design, appropriate statistical methods 603
and independent data (when available), without omitting negative results in 604
downstream reports [111,112]. 605
Emerging applications 606
Despite the challenges highlighted in the previous section, omic data analysis will 607
probably remain fundamental in numerous contexts and spread to new ones. Given the 608
complementary advantages of GSMM-generated fluxomes and other omic data, their 609
integration has therefore the potential for many novel applicative scenarios. As long as 610
steady-state metabolism is deemed relevant to the task at hand, CBM can be employed 611
to extend the omic or multi-omic data array, and machine learning techniques can be 612
used to identify hidden patterns. For instance, metabolic engineering could enormously 613
benefit from integrative biological models, which are more efficient and cost-effective 614
than empirical trials [113], in terms of both pathway design [20,85] and bioprocess 615
parameters [70, 86, 114]. Further, CBM extensions for modelling dynamic conditions can 616
overcome the intrinsic limitations of FBA, and open the door to another range of 617
applications. In spite of this, only a few studies have investigated this scenario so far, as 618
visible in Table 1. 619
Our survey also shows that many previous studies dealt with bacterial systems, in 620
particular E. coli, which is arguably the organism with the most highly curated GSMMs. 621
However, for several eukaryotic organisms - including human - constraint-based models 622
are now available, with increasing scope and precision, which constitute a promising 623
platform for integrative biological models. Initial studies have demonstrated this in the 624
context of human aging and disorders [84,88], as well as for drug development [68,83]. 625
The accumulating wealth of data extracted from human tissues is a particularly 626
valuable resource, which has however yet to be fully exploited through data- and 627
knowledge-driven approaches. This union has the potential to unveil novel clinical 628
biomarkers and drug targets if properly implemented in omic studies. 629
Moreover, there are emerging research areas that are likely to require strong 630
analytical and automation skills in the near future. In particular, we refer to those 631
applications that require GSMMs of growing size, such as for cell populations and 632
microbial communities. At present, CBM can be used to describe multiple cell types, 633
tissues [115] or even the heterogeneity within cell populations [116]. Given that no cell 634
lives in isolation, all these models will be increasingly important to understand its 635
interactions and behavior in larger systems. At the same time, focusing on individual 636
cells is increasingly revealing essential in fields like cancer biology, where single-cell 637
technologies are being improved and expanded to new omic layers. Single-cell RNA-seq 638
alone will make the amount of data generated scale up to the millions of samples, or 639
even higher numbers [34]. The spread of these technologies can further fuel the 640
emergence of a larger omic-data era, with the associated challenges in terms of data 641
analysis and interpretation. Even in this context, data- and knowledge-driven 642
computational tools appear essential to cope with these challenges. 643
Finally, as mentioned above, CBM is extensible to biomolecular domains other than 644
metabolism. Efforts have particularly focused on integrated constraint-based models of 645
gene expression and metabolism [99,100]. The formulation and validation of novel 646
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constraints could aid in developing further methods for multi-omic data mining, but at 647
the same time it poses challenges associated with the increase in knowledge-driven 648
model size and heterogeneity. 649
In all these contexts, we believe that effectively combining machine learning and 650
CBM allows achieving a richer and more meaningful mechanistic comprehension of 651
inherently multi-omic system. New integrative approaches are also expected to 652
ultimately contribute to the progress of applicative fields such as biotechnology, 653
bioengineering and biomedicine. 654
Building on common mathematical roots: towards predictive 655
and interpretable biological models 656
One last aspect of pressing importance concerns the trustworthiness of integrative data- 657
and knowledge-driven models, and their capacity to produce novel insights. 658
Interpretability is a desirable property for any mathematical model, and constitutes a 659
particularly delicate and widespread criticality in machine learning. Indeed, most 660
automatically-generated models are complex and provide no direct explanation for their 661
predictions. At the same time, interpreting results, generating hypotheses and testing 662
them is imperative to maintain scientific rigor [117]. As discussed before, in this context, 663
model interpretation relies on model transparency and post-hoc analyses [118]. 664
Transparency refers to the human understanding of a whole model, a learning algorithm 665
or their parts, variables and parameters. For example, in multiple kernel learning the 666
weights assigned to input kernels can in some sense be regarded as their contribution to 667
the given task. Alternatively, it is possible to infer relationships between input and 668
output through additional algorithms or reasoning applied a posteriori. For instance, 669
some methods can determine data samples whose predictions are similar, or they can 670
compute local dependencies on input features. 671
Note that interpretability does not uniquely depend on the data-driven model form, 672
but also on the input preprocessing. A neural network trained on intuitively meaningful 673
features learns a data representation that can be visualized and reasoned upon more 674
easily than a linear model trained on heavily processed features. 675
It can be therefore argued that CBM constitutes a vehicle for obtaining biological 676
knowledge in the form of coherent information equipped with mechanistic relations at a 677
single-reaction level. From this point of view, the generation of flux data from a 678
condition-specific GSMM can be regarded as an elaborate but transparent feature 679
engineering step, where a fluxome is the result of combining available omics with expert 680
knowledge and mathematical optimization. Therefore, we believe that CBM could be 681
the key to building more interpretable machine learning models, for instance by 682
providing variables of clear meaning [68,72]. 683
Perhaps even more importantly, paths for building more interpretable and 684
mechanistically meaningful biological models exist also on a methodological level. In 685
particular, it may be useful to consider that both machine learning methods and 686
FBA-based approaches are grounded in mathematical programming (also called 687
mathematical optimization), even though from distinct points of view. 688
In machine learning, optimization tasks target any cost function that is assumed to 689
minimize the true predictive error and allow the final model to generalize. Like in 690
traditional mathematical optimization research, this discipline seeks to formulate 691
investigative questions in terms of tractable and scalable problems. In addition, other 692
qualities such as easy implementation and interpretation are important, disregarding 693
high accuracy and robustness across wide classes of problems [119]. Many of these goals 694
are shared also by metabolic CBM. First, tractability and scalability remain of primary 695
interest, especially with the growing size of GSMMs and microbial community models. 696
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Second, highly precise solutions are not indispensable, as long as they define the 697
phenotypic state(s) associated with prior assumptions. In fact, the use of regularization 698
is starting to be recognized as a standard in FBA with the goal of identifying more 699
realistic solutions, especially when the full flux distribution is used for inference or 700
post-processing [52]. Moreover, the ease in implementation and interpretation of 701
FBA-related approaches is usually guaranteed by embedding physical, biochemical or 702
evolutionary assumptions. 703
This underlying connection can potentially be exploited to develop novel hybrid 704
methods and provide a second way towards more transparent biological models. For 705
instance, the learning problem can be formulated by integrating constraints borrowed 706
from a knowledge-driven model. This idea has been already implemented both in the 707
context of unsupervised fluxomic analysis [77, 78] and supervised fluxomic analysis [71], 708
as described in Section Combining constraint-based analysis and machine learning. 709
However, the existing case studies are limited and more work is needed to understand 710
how to effectively integrate mechanistic biological information in data-driven algorithms, 711
especially given their variety and heterogeneity. Although challenging, the idea appears 712
particularly promising if extended to multi-view learning methods, that would thereby 713
fully leverage an expanded combination of data and knowledge. 714
Conclusion 715
The use of machine and deep learning in computational and systems biology will keep 716
growing in parallel with the rapid advancement of high-throughput omic technologies. 717
However, extensions of current methodologies are needed to adapt to the heterogeneous, 718
multi-dimensional nature of omic data. Here we have explored the joint application of 719
machine learning and genome-scale metabolic modelling in the context of multi-omic 720
analysis, evaluating strengths and pitfalls in developing hybrid methods that draw from 721
both fields. Machine learning is a valuable tool for deconstructing biological complexity, 722
for the purposes of condensing high-volume multi-omic datasets and extracting relevant 723
outputs from them. In turn, CBM makes it possible to analyse metabolic activities 724
associated with distinct properties or states specific to each cell, tissue or community. 725
This is achieved through multi-omic data integration and the estimation of an 726
additional (flux)omic layer that is closer to cellular phenotype. 727
Constraint-based modelling can provide ways to inject mechanistic knowledge within 728
novel multi-view methods, aiding in the achievement of data- and knowledge-driven 729
analysis of biological systems. Given the increasing recognition of the importance of 730
metabolism and mechanism-aware omic data analysis in a range of biomedical and 731
biotechnological problems, we envisage that this multi-omic machine learning approach 732
could be useful to researchers across computational biology. 733
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